Nicholas Investment Partners’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,576,754
Closed -$7.13M 204
2022
Q2
$7.13M Sell
1,576,754
-4,117
-0.3% -$24.5K 0.67% 48
2022
Q1
$12.7M Buy
1,580,871
+600,065
+61% +$5.29M 0.9% 37
2021
Q4
$11.4M Buy
980,806
+399,202
+69% +$4.78M 0.72% 50
2021
Q3
$7.21M Buy
+581,604
New +$6.56M 0.53% 74

Other funds holding SLGC

Nicholas Investment Partners's SLGC Position: Q3 2022 in Review

Nicholas Investment Partners sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q3 2022, closing a stake of 1,576,754 shares — an estimated $7.13M sold.

Nicholas Investment Partners first reported a position in SLGC in Q3 2021 and held it in 4 quarters. The position peaked at $12.7M in Q1 2022. 126 funds tracked by Wall St. Rank hold SLGC as of Q3 2022.

  • Nicholas Investment Partners reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Nicholas Investment Partners sold 1,576,754 SomaLogic, Inc. Class A Common Stock shares in Q3 2022, an estimated $7.13M.
  • Nicholas Investment Partners first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 4 quarters.
  • Nicholas Investment Partners's SomaLogic, Inc. Class A Common Stock position peaked at $12.7M in Q1 2022.
  • 126 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q3 2022.

Based on Nicholas Investment Partners's 13F filing for Q3 2022, filed 14 Nov 2022.